A Rare Case of Regorafenib-Induced ST-Elevation Myocardial Infarction

Regorafenib is an oral multi-kinase inhibitor that is used in the treatment of chemotherapy-resistant metastatic colorectal carcinoma. However, multi-kinase inhibitors have been known to cause cardiac side effects, most notably hypertension. Myocardial ischemia is a very extraordinary adverse effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Karki, Sadichhya, Deenadayalan, Vaishali, Shrestha, Prajwal, Dhungel, Samriddh, Vij, Aviral
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10312477/
https://www.ncbi.nlm.nih.gov/pubmed/37398771
http://dx.doi.org/10.7759/cureus.39779

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10312477/
https://www.ncbi.nlm.nih.gov/pubmed/37398771
http://dx.doi.org/10.7759/cureus.39779

Ejemplares similares